Gossamer Bio Inc (GOSS)

NASDAQ
8.560
-0.170(-1.95%)
After Hours
8.380
-0.180(-2.103%)
- Real-time Data
  • Volume:
    2,382,220
  • Day's Range:
    8.290 - 9.030
  • 52 wk Range:
    5.640 - 15.195

GOSS Overview

Prev. Close
8.73
Day's Range
8.29-9.03
Revenue
-
Open
8.75
52 wk Range
5.64-15.195
EPS
-2.88
Volume
2,382,220
Market Cap
792.83M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,347,889
P/E Ratio
-3.03
Beta
0.877
1-Year Change
-20.81%
Shares Outstanding
92,620,113
Next Earnings Date
Mar 24, 2023
What is your sentiment on Gossamer Bio?
or
Market is currently closed. Voting is open during market hours.

Gossamer Bio Inc News

Gossamer Bio Inc Analysis

Gossamer Bio Inc Company Profile

Gossamer Bio Inc Company Profile

Employees
185

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Read More

Analyst Price Target

Average18.154 (+112.08% Upside)
High25
Low14
Price8.56
No. of Analysts13
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellStrong SellStrong Sell
Technical IndicatorsBuySellStrong SellStrong SellStrong Sell
SummaryNeutralSellStrong SellStrong SellStrong Sell
  • 🚀🚀🚀🚀🚀🚀🚀 soon
    0
  • rocket 2day
    0